Majem, M., Álvarez, R., Ortega, A.L., Ruiz de Alda, L., Gordo, R., García, J.F., Ivanova-Markova, Y., González-Domínguez, A., Sánchez San Cristóbal, R. and Rojo, F. 2022. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain. Global and Regional Health Technology Assessment. 9, 1 (Sep. 2022), 82–90. DOI:https://doi.org/10.33393/grhta.2022.2449.